Search

Displaying results 8631 - 8640 of 10000 in total
  1. Drug

    AN-2718

    go.drugbank.com/drugs/DB12810
    Investigational

    An2718 has been used in trials studying Tinea Pedis.

  2. Drug

    Irdabisant

    go.drugbank.com/drugs/DB12900
    Investigational

    Irdabisant has been used in trials studying Cognitive Impairment.

  3. Drug

    Plocabulin

    go.drugbank.com/drugs/DB13137
    Investigational

    PM060184 has been used in trials studying Solid Tumors.

  4. Drug

    Bacillus calmette-guerin substrain danish 1331 live antigen

    go.drugbank.com/drugs/DB12386
    Investigational

    BCG SSI has been used in trials studying Tuberculosis.

  5. Drug

    Raclopride

    go.drugbank.com/drugs/DB12518
    Investigational

    Raclopride has been used in trials studying Parkinson Disease.

  6. Drug

    CP-609754

    go.drugbank.com/drugs/DB12640
    Investigational

    LNK 754 has been investigated in Mild Alzheimer's Disease.

  7. Drug

    Gold

    go.drugbank.com/drugs/DB14154
    Investigational

    A yellow metallic element with the atomic symbol Au, atomic number 79, and atomic weight 197. It is used in jewelry, goldplating of other metals, as currency, and in dental restoration. … Many of its clinical applications, such as ANTIRHEUMATIC AGENTS, are in the form of its salts.

  8. Drug

    Clopamide

    go.drugbank.com/drugs/DB13792
    Investigational

    Clopamide is an oral diuretic agent with antihypertensive activity. Like thiazide diuretics, it has an aromatic sulfonamide base but with no double-ring structure.

  9. Drug

    Lifirafenib

    go.drugbank.com/drugs/DB14773
    Investigational

    Lifirafenib is under investigation in clinical trial NCT03641586 (The Study of BGB-283 in Chinese Subjects With Local Advanced or Metastatic Malignant Solid Tumor).

  10. Drug

    Prasinezumab

    go.drugbank.com/drugs/DB14788
    Investigational

    Prasinezumab is under investigation in clinical trial NCT03100149 (A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease).